Loading…
Iconovo amended its development deal with Amneal for a generic version of Symbicort to add US and Chinese marketing rights for Amneal and Nordic region marketing rights for Iconovo, more than doubling potential future royalty income. Iconovo also launched a new pharma division, Iconovo Pharma.